Product

FXI-GalNAc-siRNA

Aliases

FXI-GalNAc-siRNA Solution for Injection

1 clinical trial

1 indication

Indication

Factor XI Deficiency

Clinical trial

Single-center, Randomized, Double-blind, Placebo-controlled, Sequential Cohort Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAD of FXI-GalNAc-siRNA When Administered Subcutaneously to Healthy Subjects.

Status: Recruiting, Estimated PCD: 2024-05-01